Depot Extracts for Venom Immunotherapy: A Delphi Consensus on Safety and Efficacy

Clinical & Experimental Allergy 2026

View at publisher
Authors: Valerio Pravettoni, Matteo Martini, Donatella Bignardi, Alessandro Buonomo, M. Cilia, Domenico Gargano, Marina Mauro, F Murzilli, Luisa Ricciardi, M. Beatrice Bilò, the Allergy Venom Expert group
DOI: 10.1111/cea.70278
Cited by: 2
References: 8

Abstract

Summary A Delphi consensus, funded by an immunotherapy manufacturer, was reached on Depot Venom Immunotherapy (dVIT). dVIT safety is similar to aqueous VIT (rush and ultra‐rush protocols), with immunological specific enhancements.

Fields of Study & Subjects

Food Allergy and Anaphylaxis Research Allergic Rhinitis and Sensitization Healthcare and Venom Research

Publication details

Journal / source
Clinical & Experimental Allergy
Publisher
Wiley
Volume
56
Issue
7
Pages
819–822
Publication date
10 March 2026
Language
EN